Close Menu

NEW YORK – NantHealth said Thursday after the close of the market that its fourth quarter revenues ticked up less than 1 percent year over year.

CFO Bob Petrou said in November that the company expected to see about $18 million in sales for the fourth quarter.

For the three months ended Dec. 31, 2020, the firm had slightly more than $18.6 million in total revenues compared to slightly less than $18.6 million a year ago.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.